The Avmapki Fakzynja Co-Pack marks the first FDA-approved treatment for adult patients with KRAS-mutated recurrent low-grade ...

While expressing a desire for revenue growth is common, understanding the “why” behind that intention is crucial. Delving ...

Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, outlines the recent shift in the patient services industry towards a hybrid hub model for ...

Interim results from the ongoing Phase III ASSURE trial demonstrated that Livdelzi maintained a consistent biochemical ...

The use of RWD data in place of placebo groups is improving various elements across the clinical trial space.

In an effort to combat the state’s shortage of primary care physicians, Blue Cross Blue Shield of Massachusetts is offering ...

Founder and CEO of Alume Biosciences, Quyen Nguyen, MD, PhD, discusses nerve regeneration, nerve visualization and the reason behind what she does at Alume Biosciences.

Country is poised to offer growth-channel opportunities for global pharma companies ready to scale access, innovation, and ...

Top-line results from two pivotal Phase III trials found that MR-107A-02 significantly reduced pain intensity following ...

The idea of creating a gray zone in the payer message is to take the onus off of having to heavily discount for equal access ...

The pharma tech company announced a deal with Starvision to roll out its services across the network over the next five years ...

With this is mind, Abbott announced a new program that combines one of the most popular sports in the world with education ...